DK0642334T3 - Farmaceutiske og andre doseringsformer - Google Patents

Farmaceutiske og andre doseringsformer

Info

Publication number: DK0642334T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical; dosage forms; pectin; carbon atoms; amino acids
Prior art date: 1992-05-06

Application number

DK93911039T

Other languages

Danish (da)

English (en)

Inventor

Dilip J Gole

Paul K Wilkinson

J Desmond Davies

R Saul Levinson

Original Assignee

Janssen Pharmaceutica Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-06

Filing date

1993-05-03

Publication date

2000-04-17

1993-05-03 Application filed by Janssen Pharmaceutica Inc filed Critical Janssen Pharmaceutica Inc

2000-04-17 Application granted granted Critical

2000-04-17 Publication of DK0642334T3 publication Critical patent/DK0642334T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Birds (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Polymers & Plastics (AREA)
General Engineering & Computer Science (AREA)
Mechanical Engineering (AREA)
Molecular Biology (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK93911039T 1992-05-06 1993-05-03 Farmaceutiske og andre doseringsformer DK0642334T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US87975492A	1992-05-06	1992-05-06
PCT/US1993/004201 WO1993023017A1 (en)	1992-05-06	1993-05-03	Pharmaceutical and other dosage forms

Publications (1)

Publication Number	Publication Date
DK0642334T3 true DK0642334T3 (da)	2000-04-17

Family

ID=25374827

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93911039T DK0642334T3 (da)	1992-05-06	1993-05-03	Farmaceutiske og andre doseringsformer

Country Status (28)

Country	Link
EP (1)	EP0642334B1 (sv)
JP (1)	JPH07508019A (sv)
KR (1)	KR100194241B1 (sv)
CN (1)	CN1085081A (sv)
AT (1)	ATE183387T1 (sv)
BG (1)	BG62681B1 (sv)
CA (1)	CA2135062C (sv)
CL (1)	CL2004001180A1 (sv)
CY (1)	CY2175B1 (sv)
CZ (1)	CZ283882B6 (sv)
DE (1)	DE69326063T2 (sv)
DK (1)	DK0642334T3 (sv)
ES (1)	ES2136662T3 (sv)
FI (1)	FI111333B (sv)
GR (1)	GR3031180T3 (sv)
HK (1)	HK1010693A1 (sv)
HU (2)	HU227532B1 (sv)
IL (1)	IL105553A (sv)
MY (1)	MY112231A (sv)
NO (1)	NO308065B1 (sv)
NZ (1)	NZ252526A (sv)
PL (1)	PL172354B1 (sv)
RO (1)	RO112990B1 (sv)
RU (1)	RU2131244C1 (sv)
SG (1)	SG47430A1 (sv)
SK (1)	SK280129B6 (sv)
TW (1)	TW380053B (sv)
WO (1)	WO1993023017A1 (sv)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5837276A (en) *	1994-09-02	1998-11-17	Delab	Apparatus for the delivery of elongate solid drug compositions
US5582591A (en) *	1994-09-02	1996-12-10	Delab	Delivery of solid drug compositions
GB9504201D0 (en) *	1995-03-02	1995-04-19	Scherer Ltd R P	Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) *	1995-08-18	1995-10-25	Scherer Ltd R P	Pharmaceutical compositions
DE19539574A1 (de)	1995-10-25	1997-04-30	Boehringer Mannheim Gmbh	Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
FR2740686B1 (fr) *	1995-11-03	1998-01-16	Sanofi Sa	Formulation pharmaceutique lyophilisee stable
CA2257303C (en) *	1996-06-17	2006-04-04	Janssen Pharmaceutica N.V.	Biconvex rapidly disintegrating dosage forms
DE69728147T2 (de) *	1996-06-17	2004-10-28	Janssen Pharmaceutica N.V.	Markieren von schnell zerfallenden dosierungsformen
KR100782897B1 (ko) *	1996-06-17	2008-04-08	얀센 파마슈티카 엔.브이.	급속붕괴제형의표시방법
KR100823524B1 (ko) *	1996-06-17	2008-11-12	얀센 파마슈티카 엔.브이.	양쪽볼록형급속붕괴제형
GB9621614D0 (en) *	1996-10-17	1996-12-11	Cultech Limited	Vitamin delivery
GB9802088D0 (en) *	1998-01-30	1998-03-25	Scherer Ltd R P	Pharmaceutical products
US6683100B2 (en)	1999-01-19	2004-01-27	Novartis Ag	Organic compounds
US6194181B1 (en)	1998-02-19	2001-02-27	Novartis Ag	Fermentative preparation process for and crystal forms of cytostatics
ATE198348T1 (de)	1998-11-11	2001-01-15	Dalli Werke Waesche & Koerperp	Verdichtetes granulat, herstellungsverfahren und verwendung als sprengmittel für gepresste formkörper
US6552024B1 (en)	1999-01-21	2003-04-22	Lavipharm Laboratories Inc.	Compositions and methods for mucosal delivery
FR2828380B1 (fr) *	2001-08-10	2005-07-29	Fontarome	Composition a structure composite contenant des substances aromatiques et/ou des substances non aromatiques volatiles et/ou sensibles aux agents exterieurs, et son procede de fabrication
WO2003072081A1 (en)	2002-02-22	2003-09-04	Pharmacia Corporation	Ophthalmic formulation with gum system
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
DE10232113A1 (de)	2002-07-16	2004-01-29	Bayer Ag	Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
JPWO2004024188A1 (ja) *	2002-09-12	2006-01-05	日本メジフィジックス株式会社	薬物の血漿蛋白質結合を制御するための製剤
US20040052853A1 (en) *	2002-09-16	2004-03-18	Cp Kelco, U.S., Inc.	Pectin films
AU2003280324A1 (en)	2002-11-26	2004-06-18	Alk-Abello A/S	Pharmaceutical allergen product
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032051A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en)	2003-08-06	2011-12-13	Gruenenthal Gmbh	Abuse-proofed dosage form
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE20321887U1 (de)	2003-11-10	2012-01-20	Allergan, Inc.	Arzneimittel umfassend niedrige Dosierungen von Desmopressin
CA2545194C (en)	2003-11-10	2014-10-21	Seymour H. Fein	Pharmaceutical compositions including low dosages of desmopressin
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
WO2006035969A1 (ja)	2004-09-28	2006-04-06	Senju Pharmaceutical Co., Ltd.	キサンタンガムおよびアミノ酸を含有する眼科用組成物
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005009241A1 (de)	2005-03-01	2006-09-07	Bayer Healthcare Ag	Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102007011485A1 (de)	2007-03-07	2008-09-11	Grünenthal GmbH	Darreichungsform mit erschwertem Missbrauch
US9492494B2 (en)	2007-06-01	2016-11-15	Kyowa Hakko Bio Co., Ltd.	Oral composition
JP5774853B2 (ja)	2008-01-25	2015-09-09	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	医薬投薬形
EP2273983B1 (en)	2008-05-09	2016-07-20	Grünenthal GmbH	Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
EP2997965B1 (en)	2009-07-22	2019-01-02	Grünenthal GmbH	Tamper-resistant dosage form for oxidation-sensitive opioids
CA2765971C (en)	2009-07-22	2017-08-22	Gruenenthal Gmbh	Hot-melt extruded controlled release dosage form
US12186426B2 (en)	2009-10-30	2025-01-07	Ix Biopharma Ltd.	Solid dosage form
ES2712989T3 (es)	2009-10-30	2019-05-17	Ix Biopharma Ltd	Forma de dosificación sólida de disolución rápida
PE20131102A1 (es)	2010-09-02	2013-10-12	Gruenenthal Chemie	Forma de dosificacion resistente a manipulacion que comprende una sal inorganica
AR082862A1 (es)	2010-09-02	2013-01-16	Gruenenthal Gmbh	Forma de dosificacion resistente a alteracion que comprende un polimero anionico
AR087359A1 (es)	2011-07-29	2014-03-19	Gruenenthal Gmbh	Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco
EA201400172A1 (ru)	2011-07-29	2014-06-30	Грюненталь Гмбх	Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
EP2819656A1 (en)	2012-02-28	2015-01-07	Grünenthal GmbH	Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
AU2013248351B2 (en)	2012-04-18	2018-04-26	Grunenthal Gmbh	Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AR096438A1 (es)	2013-05-29	2015-12-30	Gruenenthal Gmbh	Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
AU2014273227B2 (en)	2013-05-29	2019-08-15	Grunenthal Gmbh	Tamper-resistant dosage form containing one or more particles
KR20160031526A (ko)	2013-07-12	2016-03-22	그뤼넨탈 게엠베하	에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형
BR112016010482B1 (pt)	2013-11-26	2022-11-16	Grünenthal GmbH	Preparação de uma composição farmacêutica em pó por meio de criomoagem
US9468606B2 (en) *	2014-03-31	2016-10-18	Johnson & Johnson Consumer Inc.	Compostions and methods for enhancing the topical application of an acidic benefit agent
AU2015261060A1 (en)	2014-05-12	2016-11-03	Grunenthal Gmbh	Tamper resistant immediate release capsule formulation comprising Tapentadol
MX2016015417A (es)	2014-05-26	2017-02-22	Gruenenthal Gmbh	Multiparticulas protegidas contra vertido de dosis etanolico.
WO2016170097A1 (en)	2015-04-24	2016-10-27	Grünenthal GmbH	Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja)	2015-09-10	2018-09-13	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
CN116481290A (zh) *	2022-12-28	2023-07-25	常州兰陵制药有限公司	葡萄糖酸钙结晶干燥装置及方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2166074A (en)	1937-04-09	1939-07-11	Sharp & Dohme Inc	Gelatinous colloids
GB698767A (en)	1950-07-06	1953-10-21	Bayer Ag	Readily soluble dry preparations of swelling substances
US2758644A (en) *	1953-07-30	1956-08-14	Virlouvet Jacques	Control system for slatted roller blinds
US3234091A (en)	1955-07-08	1966-02-08	Ciba Geigy Corp	Shaped medicaments and process for their manufacture
DE2017373A1 (de)	1969-04-15	1971-04-22	Orsymonde S A , Paris	Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
GB1548022A (en)	1976-10-06	1979-07-04	Wyeth John & Brother Ltd	Pharmaceutial dosage forms
CA1097233A (en)	1977-07-20	1981-03-10	George K. E. Gregory	Packages
JPS5913887B2 (ja)	1979-10-30	1984-04-02	株式会社ブリヂストン	溶融金属用濾過材
DE3404382A1 (de)	1984-02-08	1985-08-14	Anton Dr. 4400 Münster Härle	Saugflasche zum absaugen von sekreten aus wundhoehlen
US4697630A (en) *	1987-03-17	1987-10-06	General Clutch Corporation	Tilt mechanism for venetian blinds
US5079018A (en)	1989-08-14	1992-01-07	Neophore Technologies, Inc.	Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en)	1989-12-22	1993-06-01	Gole Dilip J	Preparation of pharmaceutical and other matrix systems by solid-state dissolution

1993
- 1993-04-29 IL IL105553A patent/IL105553A/en not_active IP Right Cessation
- 1993-05-03 DE DE69326063T patent/DE69326063T2/de not_active Expired - Lifetime
- 1993-05-03 RU RU94046029A patent/RU2131244C1/ru active
- 1993-05-03 AT AT93911039T patent/ATE183387T1/de active
- 1993-05-03 ES ES93911039T patent/ES2136662T3/es not_active Expired - Lifetime
- 1993-05-03 RO RO94-01770A patent/RO112990B1/ro unknown
- 1993-05-03 CZ CZ942654A patent/CZ283882B6/cs not_active IP Right Cessation
- 1993-05-03 NZ NZ252526A patent/NZ252526A/xx not_active IP Right Cessation
- 1993-05-03 WO PCT/US1993/004201 patent/WO1993023017A1/en active IP Right Grant
- 1993-05-03 HU HU9403190A patent/HU227532B1/hu unknown
- 1993-05-03 KR KR1019940703516A patent/KR100194241B1/ko not_active Expired - Lifetime
- 1993-05-03 SG SG1996001213A patent/SG47430A1/en unknown
- 1993-05-03 DK DK93911039T patent/DK0642334T3/da active
- 1993-05-03 PL PL93305975A patent/PL172354B1/pl unknown
- 1993-05-03 SK SK1320-94A patent/SK280129B6/sk not_active IP Right Cessation
- 1993-05-03 JP JP6503621A patent/JPH07508019A/ja not_active Withdrawn
- 1993-05-03 CA CA002135062A patent/CA2135062C/en not_active Expired - Lifetime
- 1993-05-03 EP EP93911039A patent/EP0642334B1/en not_active Expired - Lifetime
- 1993-05-04 MY MYPI93000832A patent/MY112231A/en unknown
- 1993-05-06 CN CN93106967A patent/CN1085081A/zh active Pending
- 1993-06-09 TW TW082104563A patent/TW380053B/zh not_active IP Right Cessation
1994
- 1994-11-03 BG BG99158A patent/BG62681B1/bg unknown
- 1994-11-04 FI FI945198A patent/FI111333B/sv not_active IP Right Cessation
- 1994-11-04 NO NO944207A patent/NO308065B1/no not_active IP Right Cessation
1995
- 1995-06-27 HU HU95P/P00465P patent/HU211549A9/hu unknown
1998
- 1998-10-29 HK HK98111598A patent/HK1010693A1/xx not_active IP Right Cessation
1999
- 1999-09-08 GR GR990402273T patent/GR3031180T3/el unknown
2000
- 2000-06-16 CY CY0000026A patent/CY2175B1/xx unknown
2004
- 2004-05-20 CL CL200401180A patent/CL2004001180A1/es unknown

Also Published As

Publication number	Publication date
HU227532B1 (en)	2011-07-28
GR3031180T3 (en)	1999-12-31
SK132094A3 (en)	1995-07-11
HU211549A9 (en)	1995-12-28
CA2135062C (en)	1999-05-25
CA2135062A1 (en)	1993-11-25
MY112231A (en)	2001-05-31
NO944207D0 (no)	1994-11-04
CN1085081A (zh)	1994-04-13
KR100194241B1 (ko)	1999-06-15
FI111333B (sv)	2003-07-15
FI945198A0 (sv)	1994-11-04
KR950700728A (ko)	1995-02-20
EP0642334B1 (en)	1999-08-18
EP0642334A1 (en)	1995-03-15
CZ265494A3 (en)	1995-02-15
ATE183387T1 (de)	1999-09-15
CY2175B1 (en)	2002-08-23
NO308065B1 (no)	2000-07-17
SK280129B6 (sk)	1999-08-06
NO944207L (no)	1994-11-04
DE69326063T2 (de)	2000-03-16
CZ283882B6 (cs)	1998-06-17
DE69326063D1 (de)	1999-09-23
ES2136662T3 (es)	1999-12-01
IL105553A0 (en)	1993-08-18
NZ252526A (en)	1995-09-26
CL2004001180A1 (es)	2005-06-03
HK1010693A1 (en)	1999-06-25
PL172354B1 (pl)	1997-09-30
BG99158A (bg)	1995-05-31
JPH07508019A (ja)	1995-09-07
BG62681B1 (bg)	2000-05-31
SG47430A1 (en)	1998-04-17
WO1993023017A1 (en)	1993-11-25
IL105553A (en)	1998-01-04
TW380053B (en)	2000-01-21
AU677198B2 (en)	1997-04-17
HUT68224A (en)	1995-06-28
FI945198L (sv)	1994-11-04
RO112990B1 (ro)	1998-03-30
AU4232293A (en)	1993-12-13
RU2131244C1 (ru)	1999-06-10
RU94046029A (ru)	1996-11-10

Publication	Publication Date	Title
DK0642334T3 (da)	2000-04-17	Farmaceutiske og andre doseringsformer
MX9206851A (es)	1993-05-01	Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
ES2161693T3 (es)	2001-12-16	Morfogenesis inducida por proteinas.
NO892407L (no)	1989-12-14	Aminosyrederivater.
NO166267C (no)	1991-06-26	Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet.
ATE74003T1 (de)	1992-04-15	Waessriges pharmazeutisches praeparat.
NO901399L (no)	1990-10-01	Aminosyrederivater.
DE3889536D1 (de)	1994-06-16	Behandlung von krebs mit somatostatin und mit analogen davon.
AR042345A2 (es)	2005-06-15	Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
NO903832L (no)	1991-03-05	Aminosyrederivater.
ATE220688T1 (de)	2002-08-15	Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen
ES2056153T3 (es)	1994-10-01	Expectorante que comprende un derivado hidroxialquilcisteina.
DK482185A (da)	1986-04-23	Peptider, deres fremstilling og anvendelse som laegemidler
YU108691A (sh)	1994-01-20	Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
NO901533D0 (no)	1990-04-04	Aminosyrederivater.
ES2099704T3 (es)	1997-06-01	Purificacion de albumina.
MX9102088A (es)	1993-01-01	Complejos que contienen acidos s(+) fenilalcanos y alfa-aminoacidos
ATE93527T1 (de)	1993-09-15	Peptide und deren benutzung.
NO894594D0 (no)	1989-11-17	Farmasoeytiske sammensetninger omfattende labdan diterpenoid-derivater og pyrimido(6,1-a)isoquinolin-4-ono-derivater.
NZ228023A (en)	1991-10-25	24(r)-scymnol; preparatory processes and pharmaceutical compositions
ES2072869T3 (es)	1995-08-01	Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
DE3866747D1 (de)	1992-01-23	Jod enthaltende pharmazeutische zubereitung.
DE59107762D1 (de)	1996-06-05	Komplexe, enthaltend S(+)-Phenyl-alkansäuren und alpha-Hydroxy-alkansäuren
NO901519L (no)	1990-10-05	Aminosyrederivater.
SE9100284D0 (sv)	1991-01-30	Novel peptide